Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Abstract B063: Unveiling the immune landscape of recurrent, MYC-driven medulloblastoma

Ben Draper, Dean Thompson, Alaide Morcavallo, Bethany Remeniuk, John Anderson, Louis Chesler, Steve Clifford, Frank Huang, Laura K. Donovan

Cancer Res (2024) 84 (17_Supplement): B063.

https://doi.org/10.1158/1538-7445.PEDIATRIC24-B063

Published: 05 September 2024

View articletitled, Abstract B063: Unveiling the immune landscape of recurrent, MYC-driven medulloblastoma

Journal Articles

Abstract B035: Stratified Medicine Paediatrics2 – advancing precision medicine in paediatric cancer

Aditi Vedi, Sally George, Thomas Jacques, Isidro Cortes-Ciriano, Michael Hubank, Andrew Beggs, Maggie Cheang, Nuria Porta, Ciaran Hutchinson, Louise Hopkins, Amina Bukhari, Regan Barfoot, Steve Clifford, David O'Connor, Timothy Ritzmann, Amos Burke, John Anderson, Darren Hargrave, Louis Chesler

Cancer Res (2024) 84 (17_Supplement): B035.

https://doi.org/10.1158/1538-7445.PEDIATRIC24-B035

Published: 05 September 2024

View articletitled, Abstract B035: Stratified Medicine Paediatrics2 – advancing precision medicine in paediatric cancer

Journal Articles

Abstract A036 The Stratified Medicine Paediatrics programme for cancers of childhood: Cell free DNA and serial tumour sequencing identifies subtype specific evolution and epigenetic states

Cancer Res (2024) 84 (17_Supplement): A036.

https://doi.org/10.1158/1538-7445.PEDIATRIC24-A036

Published: 05 September 2024

View articletitled, Abstract A036 The Stratified Medicine Paediatrics programme for cancers of childhood: Cell free DNA and serial tumour sequencing identifies subtype specific evolution and epigenetic states

Journal Articles

Shortwave Infrared Imaging Enables High-Contrast Fluorescence-Guided Surgery in Neuroblastoma

Laura Privitera, Dale J. Waterhouse, Alessandra Preziosi, Irene Paraboschi, Olumide Ogunlade, Chiara Da Pieve, Marta Barisa, Olumide Ogunbiyi, Gregory Weitsman, J. Ciaran Hutchinson, Kate Cross, Lorenzo Biassoni, Danail Stoyanov, Neil Sebire, Paul Beard, Paolo De Coppi, Gabriela Kramer-Marek, John Anderson, Stefano Giuliani

Cancer Res (2023) 83 (12): 2077–2089.

https://doi.org/10.1158/0008-5472.CAN-22-2918

Published: 15 June 2023

View articletitled, Shortwave Infrared Imaging Enables High-Contrast Fluorescence-Guided Surgery in Neuroblastoma

Includes: Multimedia, Supplementary data

Journal Articles

Noninvasive MRI Native T₁ Mapping Detects Response to MYCN-targeted Therapies in the Th-MYCN Model of Neuroblastoma

Konstantinos Zormpas-Petridis, Evon Poon, Matthew Clarke, Neil P. Jerome, Jessica K.R. Boult, Matthew D. Blackledge, Fernando Carceller, Alexander Koers, Giuseppe Barone, Andrew D.J. Pearson, Lucas Moreno, John Anderson, Neil Sebire, Kieran McHugh, Dow-Mu Koh, Louis Chesler, Yinyin Yuan, Simon P. Robinson, Yann Jamin

Cancer Res (2020) 80 (16): 3424–3435.

https://doi.org/10.1158/0008-5472.CAN-20-0133

Published: 14 August 2020

View articletitled, Noninvasive MRI Native T1 Mapping Detects Response to MYCN-targeted Therapies in the Th-MYCN Model of Neuroblastoma

Includes: Supplementary data

Journal Articles

In Vivo Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis

Cancer Res (2019) 79 (20): 5382–5393.

https://doi.org/10.1158/0008-5472.CAN-18-2759

Published: 15 October 2019

View articletitled, In Vivo Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis

Includes: Supplementary data

Journal Articles

MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic Treatment

Cancer Res (2019) 79 (11): 2978–2991.

https://doi.org/10.1158/0008-5472.CAN-18-3412

Published: 03 June 2019

View articletitled, MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic Treatment

Includes: Supplementary data

Journal Articles

Abstract CT145: A Cancer Research UK phase I trial of anti-GD2 chimeric antigen receptor (CAR) transduced T-cells (1RG-CART) in patients with relapsed or refractory neuroblastoma

Cancer Res (2018) 78 (13_Supplement): CT145.

https://doi.org/10.1158/1538-7445.AM2018-CT145

Published: 01 July 2018

View articletitled, Abstract CT145: A Cancer Research UK phase I trial of anti-GD2 chimeric antigen receptor (CAR) transduced T-cells (1RG-CART) in patients with relapsed or refractory neuroblastoma

Journal Articles

Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity

Francis Mussai, Sharon Egan, Stuart Hunter, Hannah Webber, Jonathan Fisher, Rachel Wheat, Carmel McConville, Yordan Sbirkov, Kate Wheeler, Gavin Bendle, Kevin Petrie, John Anderson, Louis Chesler, Carmela De Santo

Cancer Res (2015) 75 (15): 3043–3053.

https://doi.org/10.1158/0008-5472.CAN-14-3443

Published: 02 August 2015

View articletitled, Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity

Includes: Supplementary data

Journal Articles

Abstract LB-328: SHP-1, p53 and Y674/Y675-phosphorylated-trkA: a molecular pathway and prognostic marker for neuroblastoma

Gehad Youssef, Cheryl Gillet, Dyanne Rampling, Mirza Chagtay, Alex Virasami, Neil Sebire, John Anderson, Ximena Montano

Cancer Res (2014) 74 (19_Supplement): LB-328.

https://doi.org/10.1158/1538-7445.AM2014-LB-328

Published: 01 October 2014

View articletitled, Abstract LB-328: SHP-1, p53 and Y674/Y675-phosphorylated-trkA: a molecular pathway and prognostic marker for neuroblastoma

Journal Articles

Abstract 5454: Novel STAT3:STAT3 small-molecule inhibitors as potential anticancer agents

Mohammad R. Haque, Giovanna Zinzalla, Samantha L. Kaye, Shozeb Haider, B. Piku Basu, John Anderson, Khondaker M. Rahman, Dyeison Antonow, Samantha Essex, Jonathan Palmer, Edwin Nkansah, Fyeza Hasan, Daniel Morgenstern, Andrew F. Wilderspin, Stephen Neidle, David E. Thurston

Cancer Res (2010) 70 (8_Supplement): 5454.

https://doi.org/10.1158/1538-7445.AM10-5454

Published: 15 April 2010

View articletitled, Abstract 5454: Novel STAT3:STAT3 small-molecule inhibitors as potential anticancer agents

Journal Articles

Abstract 5742: Hand pattern and prostate cancer risk

Aneela A. Rahman, Artitaya Lophatananon, Duncan Harris, John Anderson, Douglas Easton, Tim Key, Richard Pocock, David Dearnaley, Michelle Guy, Steven Edwards, Lynne O'Brien, Rosemary A. Wilkinson, Amanda L. Hall, Emma Sawyer, Elizabeth Page, Jo-Fen Liu, Rosalind Eeles, Kenneth Muir

Cancer Res (2010) 70 (8_Supplement): 5742.

https://doi.org/10.1158/1538-7445.AM10-5742

Published: 15 April 2010

View articletitled, Abstract 5742: Hand pattern and prostate cancer risk

Journal Articles

Migratory and Antigen Presentation Functions of IFN-Producing Killer Dendritic Cells

Nourredine Himoudi, Mengyong Yan, Gerben Bouma, Daniel Morgenstern, Rebecca Wallace, Ben Seddon, Jo Buddle, Ayad Eddaoudi, Steven J. Howe, Nichola Cooper, John Anderson

Cancer Res (2009) 69 (16): 6598–6606.

https://doi.org/10.1158/0008-5472.CAN-09-0501

Published: 12 August 2009

View articletitled, Migratory and Antigen Presentation Functions of IFN-Producing Killer Dendritic Cells

Includes: Supplementary data

Journal Articles

Development of Cellular Immune Responses against PAX5, a Novel Target for Cancer Immunotherapy

Mengyong Yan, Nourredine Himoudi, Martin Pule, Neil Sebire, Edmund Poon, Allison Blair, Owen Williams, John Anderson

Cancer Res (2008) 68 (19): 8058–8065.

https://doi.org/10.1158/0008-5472.CAN-08-0153

Published: 30 September 2008

View articletitled, Development of Cellular Immune Responses against PAX5, a Novel Target for Cancer Immunotherapy

Includes: Supplementary data

Journal Articles

The in silico identification and evaluation of potential small molecule inhibitors of the Met Kinase Receptor

Michal Luzac, John Anderson, John Roffey, Daljit Bahia, David Evans, Stephen Neidle, David Thurston, Philip Howard

Cancer Res (2007) 67 (9_Supplement): 4738.

Published: 01 May 2007

View articletitled, The in silico identification and evaluation of potential small molecule inhibitors of the Met Kinase Receptor

Journal Articles

Finger pattern and prostate cancer risk: A case-control study using BPH and community-based population as controls

Kenneth Muir, Artitaya Lophatananon, Sarah Armstrong, Duncann Harriss, John Anderson

Cancer Res (2004) 64 (7_Supplement): 250–251.

Published: 01 April 2004

View articletitled, Finger pattern and prostate cancer risk: A case-control study using BPH and community-based population as controls

Journal Articles

Gains, Losses, and Amplification of Genomic Material in Rhabdomyosarcoma Analyzed by Comparative Genomic Hybridization

Stephen Weber-Hall, John Anderson, Aidan McManus, Syuiti Abe, Takayuki Nojima, Ross Pinkerton, Kathy Pritchard-Jones, Janet Shipley

Cancer Res (1996) 56 (14): 3220–3224.

Published: 01 July 1996

View articletitled, Gains, Losses, and Amplification of Genomic Material in Rhabdomyosarcoma Analyzed by Comparative Genomic Hybridization

Journal Articles

Delivery of Essential Services to Alcoholics through the “Continuum of Care”

Daniel John Anderson

Cancer Res (1979) 39 (7_Part_2): 2855–2858.

Published: 01 July 1979

View articletitled, Delivery of Essential Services to Alcoholics through the “Continuum of Care”

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract B063: Unveiling the immune landscape of recurrent, MYC-driven medulloblastoma

Abstract B035: Stratified Medicine Paediatrics2 – advancing precision medicine in paediatric cancer

Abstract A036 The Stratified Medicine Paediatrics programme for cancers of childhood: Cell free DNA and serial tumour sequencing identifies subtype specific evolution and epigenetic states

Shortwave Infrared Imaging Enables High-Contrast Fluorescence-Guided Surgery in Neuroblastoma

Noninvasive MRI Native T₁ Mapping Detects Response to MYCN-targeted Therapies in the Th-MYCN Model of Neuroblastoma

In Vivo Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis

MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic Treatment

Abstract CT145: A Cancer Research UK phase I trial of anti-GD2 chimeric antigen receptor (CAR) transduced T-cells (1RG-CART) in patients with relapsed or refractory neuroblastoma

Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity

Abstract LB-328: SHP-1, p53 and Y674/Y675-phosphorylated-trkA: a molecular pathway and prognostic marker for neuroblastoma

Abstract 5454: Novel STAT3:STAT3 small-molecule inhibitors as potential anticancer agents

Abstract 5742: Hand pattern and prostate cancer risk

Migratory and Antigen Presentation Functions of IFN-Producing Killer Dendritic Cells

Development of Cellular Immune Responses against PAX5, a Novel Target for Cancer Immunotherapy

The in silico identification and evaluation of potential small molecule inhibitors of the Met Kinase Receptor

Finger pattern and prostate cancer risk: A case-control study using BPH and community-based population as controls

Gains, Losses, and Amplification of Genomic Material in Rhabdomyosarcoma Analyzed by Comparative Genomic Hybridization

Delivery of Essential Services to Alcoholics through the “Continuum of Care”

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only